$-0.21 EPS Expected for Novadaq Technologies Inc. (NVDQ)

July 18, 2017 - By Kurt Siggers

 $ 0.21 EPS Expected for Novadaq Technologies Inc. (NVDQ)

Wall Street await Novadaq Technologies Inc. (NASDAQ:NVDQ) to release earnings on July, 26. Analysts forecast earnings per share of $-0.21, up exactly $0.08 or 27.59 % from 2014’s $-0.29 EPS. After posting $-0.24 EPS for the previous quarter, Novadaq Technologies Inc.’s analysts now forecast -12.50 % EPS growth. The stock increased 0.09% or $0.01 during the last trading session, reaching $11.72. About 537,172 shares traded. Novadaq Technologies Inc. (NASDAQ:NVDQ) has declined 24.90% since July 18, 2016 and is downtrending. It has underperformed by 41.60% the S&P500.

Novadaq Technologies Inc. (NASDAQ:NVDQ) Ratings Coverage

Among 10 analysts covering Novadaq Technologies Inc (NASDAQ:NVDQ), 1 have Buy rating, 0 Sell and 9 Hold. Therefore 10% are positive. Novadaq Technologies Inc had 19 analyst reports since October 7, 2015 according to SRatingsIntel. The stock of Novadaq Technologies Inc. (NASDAQ:NVDQ) earned “Buy” rating by RBC Capital Markets on Monday, June 19. The stock has “Hold” rating by BTIG Research on Monday, June 19. The rating was upgraded by First Analysis to “Overweight” on Thursday, October 29. The rating was maintained by Wedbush with “Outperform” on Wednesday, January 11. The rating was maintained by Northland Capital with “Hold” on Monday, June 19. The company was downgraded on Thursday, July 13 by RBC Capital Markets. The rating was downgraded by Stifel Nicolaus to “Hold” on Tuesday, June 20. On Wednesday, January 11 the stock rating was maintained by RBC Capital Markets with “Outperform”. The rating was downgraded by William Blair to “Market Perform” on Wednesday, January 11. The firm earned “Buy” rating on Monday, June 19 by Canaccord Genuity.

NOVADAQ Technologies Inc. is a medical device company. The company has market cap of $677.10 million. The Firm primarily develops, makes and markets real-time fluorescence imaging products that are designed for use by surgeons in the operating room and other clinical settings where open and minimally invasive surgery or interventional procedures are performed. It currently has negative earnings. The Company’s SPY fluorescence imaging technology platform provides clinically relevant anatomic and physiologic images of blood flow in vessels and micro-vessels during a range of surgical and outpatient procedures performed in the operating room or clinic.

More news for Novadaq Technologies Inc. (NASDAQ:NVDQ) were recently published by: Nasdaq.com, which released: “NOVADAQ Mails Information Circular for Special Meeting of Shareholders” on July 12, 2017. Fool.com‘s article titled: “Why Novadaq Technologies Inc. Skyrocketed Yesterday” and published on June 20, 2017 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.